FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158189905> ?p ?o ?g. }

• W2158189905 endingPage "65" @default.
• W2158189905 startingPage "60" @default.
• W2158189905 abstract "Advances in the understanding of neural mechanisms in asthma may provide novel therapeutic approaches in the treatment of asthma. Excessive activity of cholinergic nerves may be important in asthma. Dysfunction of M2 muscarinic receptors in asthma may lead to excessive bronchoconstriction and mucus secretion and can be induced in animal models by a range of stimuli including allergen, viral infection, ozone, eosinophil products and cytokines. Cholinergic mechanisms may be especially important in certain types of patients and anticholinergic agents provide protection against bronchospasm due to psychogenic factors or beta2-blockers. Non-adrenergic non-cholinergic (NANC) mechanisms, both inhibitory (i-NANC) and excitatory (e-NANC), may play a significant role in the pathophysiology of asthma. The putative neurotransmitters, vasoactive interstinal polypeptide (VIP) and nitric oxide (NO), mediate neural bronchodilation in human airways. There does not appear to be a defect in the i-NANC system in moderate or severe asthma. e-NANC is mediated by the sensory neuropeptides substance P (SP) and the more potent bronchoconstrictor neurokinin A (NKA). Various studies suggest that the SP content of human airways is increased in asthma. Tachykinins are not only present in sensory nerves, but also are produced by inflammatory cells such as alveolar macrophages, dendritic cells, eosinophils, lymphocytes and neutrophils. They can be released into the airways by stimuli such as allergen and ozone. Evidence suggests that in addition to smooth muscle contraction, which is mediated mainly by NK2 receptors, tachykinins also cause mucus secretion, plasma extravasation and stimulate inflammatory and immune cells. These effects are mediated by NK1 receptors. Recent studies have shown that NK2 receptor antagonists such as saredutant partially inhibit NKA-induced bronchoconstriction in asthmatics. Thus, tachykinin receptor antagonists have potential as therapies for asthma." @default.
• W2158189905 created "2016-06-24" @default.
• W2158189905 creator A5036231436 @default.
• W2158189905 creator A5043549118 @default.
• W2158189905 creator A5070268822 @default.
• W2158189905 date "2000-06-01" @default.
• W2158189905 modified "2023-09-27" @default.
• W2158189905 title "Neural mechanisms in asthma" @default.
• W2158189905 cites W1969096243 @default.
• W2158189905 cites W1969377120 @default.
• W2158189905 cites W1969531702 @default.
• W2158189905 cites W1976163277 @default.
• W2158189905 cites W1985024346 @default.
• W2158189905 cites W2003763178 @default.
• W2158189905 cites W2007678048 @default.
• W2158189905 cites W2021589365 @default.
• W2158189905 cites W2035804411 @default.
• W2158189905 cites W2046470493 @default.
• W2158189905 cites W2094934462 @default.
• W2158189905 cites W2106134409 @default.
• W2158189905 cites W2115487760 @default.
• W2158189905 cites W2129384028 @default.
• W2158189905 cites W2146791137 @default.
• W2158189905 cites W2155514562 @default.
• W2158189905 cites W2160771169 @default.
• W2158189905 cites W2181658360 @default.
• W2158189905 cites W4240320089 @default.
• W2158189905 cites W4253446802 @default.
• W2158189905 doi "https://doi.org/10.1046/j.1365-2222.2000.00100.x" @default.
• W2158189905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10849478" @default.
• W2158189905 hasPublicationYear "2000" @default.
• W2158189905 type Work @default.
• W2158189905 sameAs 2158189905 @default.
• W2158189905 citedByCount "60" @default.
• W2158189905 countsByYear W21581899052012 @default.
• W2158189905 countsByYear W21581899052013 @default.
• W2158189905 countsByYear W21581899052014 @default.
• W2158189905 countsByYear W21581899052015 @default.
• W2158189905 countsByYear W21581899052016 @default.
• W2158189905 countsByYear W21581899052017 @default.
• W2158189905 countsByYear W21581899052020 @default.
• W2158189905 countsByYear W21581899052021 @default.
• W2158189905 crossrefType "journal-article" @default.
• W2158189905 hasAuthorship W2158189905A5036231436 @default.
• W2158189905 hasAuthorship W2158189905A5043549118 @default.
• W2158189905 hasAuthorship W2158189905A5070268822 @default.
• W2158189905 hasConcept C118303440 @default.
• W2158189905 hasConcept C126322002 @default.
• W2158189905 hasConcept C170493617 @default.
• W2158189905 hasConcept C18903297 @default.
• W2158189905 hasConcept C203014093 @default.
• W2158189905 hasConcept C22885893 @default.
• W2158189905 hasConcept C2776042228 @default.
• W2158189905 hasConcept C2776178081 @default.
• W2158189905 hasConcept C2776533618 @default.
• W2158189905 hasConcept C2777056410 @default.
• W2158189905 hasConcept C2777312293 @default.
• W2158189905 hasConcept C2777714996 @default.
• W2158189905 hasConcept C2779999680 @default.
• W2158189905 hasConcept C2780769369 @default.
• W2158189905 hasConcept C2781260171 @default.
• W2158189905 hasConcept C33789571 @default.
• W2158189905 hasConcept C71924100 @default.
• W2158189905 hasConcept C86803240 @default.
• W2158189905 hasConceptScore W2158189905C118303440 @default.
• W2158189905 hasConceptScore W2158189905C126322002 @default.
• W2158189905 hasConceptScore W2158189905C170493617 @default.
• W2158189905 hasConceptScore W2158189905C18903297 @default.
• W2158189905 hasConceptScore W2158189905C203014093 @default.
• W2158189905 hasConceptScore W2158189905C22885893 @default.
• W2158189905 hasConceptScore W2158189905C2776042228 @default.
• W2158189905 hasConceptScore W2158189905C2776178081 @default.
• W2158189905 hasConceptScore W2158189905C2776533618 @default.
• W2158189905 hasConceptScore W2158189905C2777056410 @default.
• W2158189905 hasConceptScore W2158189905C2777312293 @default.
• W2158189905 hasConceptScore W2158189905C2777714996 @default.
• W2158189905 hasConceptScore W2158189905C2779999680 @default.
• W2158189905 hasConceptScore W2158189905C2780769369 @default.
• W2158189905 hasConceptScore W2158189905C2781260171 @default.
• W2158189905 hasConceptScore W2158189905C33789571 @default.
• W2158189905 hasConceptScore W2158189905C71924100 @default.
• W2158189905 hasConceptScore W2158189905C86803240 @default.
• W2158189905 hasIssue "s1" @default.
• W2158189905 hasLocation W21581899051 @default.
• W2158189905 hasLocation W21581899052 @default.
• W2158189905 hasOpenAccess W2158189905 @default.
• W2158189905 hasPrimaryLocation W21581899051 @default.
• W2158189905 hasRelatedWork W130561655 @default.
• W2158189905 hasRelatedWork W1966594982 @default.
• W2158189905 hasRelatedWork W1985024346 @default.
• W2158189905 hasRelatedWork W2057586331 @default.
• W2158189905 hasRelatedWork W2081588580 @default.
• W2158189905 hasRelatedWork W2127723938 @default.
• W2158189905 hasRelatedWork W2150895402 @default.
• W2158189905 hasRelatedWork W2396818974 @default.
• W2158189905 hasRelatedWork W2406146003 @default.
• W2158189905 hasRelatedWork W3032574330 @default.
• W2158189905 hasVolume "30" @default.

• next